• Study on Trastuzumab Deruxtecan and Drug Combination for Patients with High-Risk HER2-Positive Early Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Germany Italy Poland Spain
  • Study of Relatlimab, Nivolumab, and 5-Azacytidine for Acute Myeloid Leukemia in Patients Not Eligible for Intensive Chemotherapy

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Germany
  • Long-term Safety and Efficacy Study of Gene Therapy for Choroideremia and X-Linked Retinitis Pigmentosa Using AAV2-REP1 and AAV8-RPGR in Previously Treated Patients

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany
  • Study on the Effects of VCN-01 with Nab-Paclitaxel and Gemcitabine for Patients with Advanced Pancreatic Cancer

    Not recruiting

    2 1 1
    Investigated diseases:
    Spain
  • Study on the Safety of ATreg Cells for Patients with Leukemia After Stem Cell Transplant to Reduce Graft vs Host Disease

    Not recruiting

    2 1 1
    Germany
  • Study of Insulin Treatment for Blood Glucose Control in Adult Critically Ill Patients with Stress Hyperglycemia

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study on Long-Term Safety and Efficacy of Cebsulfase Alfa for Children with Late Metachromatic Leukodystrophy Receiving Intrathecal Enzyme Replacement

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark France Germany Italy
  • Study of Mosunetuzumab and Zanubrutinib for Patients with Relapsed or Refractory Follicular Lymphoma

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Italy
  • Study of ACP-017 and Pembrolizumab for Patients with Advanced or Metastatic Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands Spain
  • Study on the Effects of Ertugliflozin and Sodium Intake on Blood Pressure in Overweight Adults with Type 2 Diabetes

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

powered by